Biobohemia Inc

Biobohemia, Inc. is a small biotechnology company based in Cambridge, Massachusetts, with a team of three employees. They have generated $2.5 million in revenue. Their website is biobohemia.com. Biobohemia is dedicated to the development of innovative cancer vaccines. Their core technology centers around a process called "cell Antigenic Essence production" which utilizes proteomics and cell culture to create a refined and controlled form of cancer cell antigens. This approach represents a significant advancement over traditional cellular cancer vaccines, which have shown promise but have yet to reach clinical trial stages. Antigenic essence technology offers several key advantages. It retains all the identifying characteristics of cancer cells, while allowing for precise control over composition and purification. This eliminates unwanted cellular "noise" and overcomes limitations imposed by MHC restrictions. As a result, this technology can both enhance existing cellular vaccine compositions and enable the creation of entirely new ones. Biobohemia is currently developing a series of potential cancer vaccine candidates under the brand name SANTAVAC. These vaccines are designed to be adaptable to a wide range of solid cancers and are being explored for both preventative and therapeutic applications.